Sinequan Depression Treatment
General Information about Sinequan
Sinequan, the brand name for Doxepin, is a drug that belongs to the TCA class, or the Tricyclic Antidepressants, which are primarily used to treat depression. Sinequan is a psychoactive drug, which means it influences the central nervous system, with the consequence of changing the moods and behavior of the patient. Sinequan is also used as an anxiolytic, accounting for its use in the treatment of anxiety disorders.
In addition, Sinequan is also antagonistic in nature. The basic ingredient in Sinequan is Doxepin hydrochloride, which is readily water-soluble crystalline white-colored powder. Since depression is caused by a disturbance in neurotransmitter, which are chemicals used by the nerve cells in the brain to communicate with each other. Some of the neurotransmitters that are influenced by Sinequan are norepinephrine, histamine, etc. In 1974, Sinequan was approved by the FDA (Food and Drugs Association)
Sinequan is well-tolerated and effective even for aged patients. However, it is not recommended and not yet given to adolescents, especially those with age below 12 years, owing to the fact there has been very little related clinical research and trials. Furthermore, Sinequan also performs the function of blocking sodium channels, thereby resulting into its use as an analgesic (drug used for pain-alleviations).